Biotricity

108 articles with Biotricity

• Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference

  2/3/2023

  Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is excited to announce that it is one of only eight companies selected to present at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference (ISC), being held in Dallas, TX.

• Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions

  1/26/2023

  Biotricity Inc. today announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists' patient use - Bioflux and Biotres TM.

• Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET

  1/23/2023

  Biotricity Inc. announced today that Company CEO Waqaas Alsiddiq has been invited to present at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, January 25th, 2023 at 8:15 a.m. ET.

• Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023

  1/17/2023

  Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced it has signed an agreement with a leading group ‎purchasing organization for national distribution of its cardiac monitoring solutions, Bioflux® and BiotresTM.

• Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth

  12/12/2022

  Biotricity, Inc. today announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.

• Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET

  11/1/2022

  Biotricity Inc. today announced it will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal 2023 second quarter and provide a business update.

• Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics

  10/26/2022

  Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the U.S. launch of Biocare Cardiac.

• Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib)

  10/4/2022

  Biotricity Inc. announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation, the most common type of cardiac arrhythmia and a leading cause of stroke.

• Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure

  9/7/2022

  Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity's innovative artificial intelligence-driven system of real-time monitoring and prediction technology, in subjects with Chronic Kidney Disease.

• Biotricity Reports Financial Results for Fiscal 2023 First Quarter

  8/15/2022

  Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced its financial results for its fiscal 2023 first quarter ended June 30, 2022.

• Biotricity to Host Fiscal First Quarter 2023 Financial Results Conference Call on August 15th at 4:30 p.m. ET

  8/5/2022

  Biotricity Inc. (NYSE:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call and webcast on Monday, August 15, 2022 at 4:30 p.m. ET to discuss its financial results for the fiscal first quarter 2023 and provide a business update.

• Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year

  7/14/2022

  Biotricity Inc. today announced its financial results for its fiscal 2022 fourth quarter and year ended March 31, 2022.

• Biotricity to Join Russell Microcap(R) Index

  6/23/2022

  Biotricity Inc. today announced that the Company is expected to join the Russell Microcap Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2022.

• Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th

  5/23/2022

  Biotricity Inc. is scheduled to present and will be participating in a fireside chat at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022.

• Biotricity Issues Shareholder Update - May 05, 2022

  5/5/2022

  Biotricity Inc. provided an update for its shareholders by Chief Executive Officer Waqaas Al-Siddiq, Ph.D., that discusses recent Company achievements and strategic initiatives to position the business for strong 2022 results, increasing scale and accelerating growth into 2023.

• Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022

  3/22/2022

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022.

• Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022

  3/8/2022

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2022.

• Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th

  3/4/2022

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced that it will attend the 34th Annual Roth Conference, being held on March 13-15, 2022 at The Ritz Carlton, Laguna Niguel in Dana Point, California.

• Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device

  2/23/2022

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced that it is now taking pre-orders for Biotres, the Company's three-lead device designed to continuously record electro-cardiogram data for early detection of cardiac arrhythmias.

• 

  BioSpace Investigates Challenges with Compensation Disparity in the Life Sciences

  2/10/2022

  72% of employers are currently experiencing a decrease in the volume of candidates applying to their jobs.